A detailed history of Ever Source Wealth Advisors, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 494 shares of ARDX stock, worth $2,553. This represents 0.0% of its overall portfolio holdings.

Number of Shares
494
Previous 494 -0.0%
Holding current value
$2,553
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.89 - $9.31 $494 - $782
-84 Reduced 14.53%
494 $3,000
Q1 2024

Jun 11, 2024

BUY
$6.05 - $9.74 $3,496 - $5,629
578 New
578 $4,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $799M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.